LAKE FOREST, Calif., April 28, 2014 /PRNewswire/ -- Cryoport, Inc. (OTCBB: CYRX) ("the Company") today announced that it is exhibiting its cryogenic logistics solutions, equipped with its cloud-based logistics management platform, the CryoportalTM, and its Cryoport Express® Packaging Solutions at the 9th Annual World Stem Cells and Regenerative Medicine Congress 2014 in London on May 20-22, 2014, at Booth #29.
Cryoport's Chief Executive Officer, Jerrell Shelton; Chief Commercial Officer, Steven Leatherman; and Commercial Director of EMEA, Soren Knudsen, will be available for partnering and networking sessions during the conference.
"We are experiencing significant interest and demand for our innovative cryogenic logistics solutions within this exciting and fast growing segment of the life science arena," stated Mr. Leatherman. "Our cryogenic logistics solutions assure both our clients and their end-users that the integrity of the commodities shipped are appropriately maintained by providing unmatched transparency, thus offering peace of mind throughout the entire documented logistics process."
Mr. Shelton added, "As the application of stem cells to regenerative medicine grows, the very face of medicine changes. Stem cell applications are broad and reach into multiple medical practices. We understand the challenges life science companies face in the frozen shipping of biologics and virtually eliminate the risks through our reliable and innovative logistics solutions."
About The World Stem Cells and Regenerative Medicine Congress
The World Stem Cells and Regenerative Medicine Congress 2014 is now in its 9th year and is Europe's largest and most senior conference and business development event for the stem cell and cell therapy industry. The World Stem Cells and Regenerative Medicine Congress brings together biopharma leaders, stakeholders, influencers and end users looking for translational research, business development and commercialisation. It is a proven conference and exhibition that delivers the innovators, disruptors and influencers from across the complete value chain. For more information on the event, please visit http://www.terrapinn.com/conference/stem-cells/?utm_source=cryoport&utm_medium=pressrelease&utm_campaign=cryoport
About Cryoport, Inc.
Cryoport provides leading-edge cryogenic logistics solutions to the life sciences industry through the combination of purpose-built proprietary packaging, information technology and specialized cold chain logistics expertise. Its competencies range from skilled, total turnkey management of the entire life sciences cold chain logistics process to complex total management solutions for outsourced cold chain logistics.
Its packaging, built around its Cryoport Express® liquid nitrogen dry vapor shippers, is validated to maintain a constant -150°C temperature for a 10-plus day dynamic shipment duration. Its information technology boast its Cryoportal™ Logistics Management Platform which manages the entire logistics process, including initial order input, document preparation, customs document preparation and clearance, integrator/courier management, shipment tracking, issue resolution, intervention, when necessary, and delivery. Cryoport uses recyclable and reusable components providing an environmentally friendly solution. Cryoport solutions can record the "chain of condition" and "chain of custody" for shipments thereby meeting the exacting requirements for scientific work and for regulatory purposes. For more information, visit www.cryoport.com.
SOURCE Cryoport, Inc.